| Number unique A-genes | 1 | 
|---|---|
| Number unique B-genes | 6 | 
| Number unique A-B gene pairs | 6 | 
| Total number of interactions | 1305 | 
| A-argument | B-argument | count | 
|---|---|---|
| MTOR | AMPK | 1176 | 
| MTOR | PRKAA2 | 59 | 
| MTOR | PRKAA1 | 51 | 
| MTOR | PRKAB1 | 16 | 
| MTOR | PRKAB2 | 2 | 
| MTOR | PRKAG1 | 1 | 
| input | recognized symbol | mapping type | 
|---|---|---|
| mtor | MTOR | Orthology Cluster | 
| input | recognized symbol | mapping type | 
|---|---|---|
| ampk | AMPK | FamPlex Concept | 
| input | recognized symbol | mapping type | 
|---|---|---|
| mtor | MTOR | Orthology Cluster | 
| input | recognized symbol | mapping type | 
|---|---|---|
| ampk | AMPK | FamPlex Concept | 
| Gene A Symbol | Gene B Symbol | Gene A Gene ID | Gene B Gene ID | Relation Types | Factuality | Fulltext Match Source | Document ID | Context | 
|---|---|---|---|---|---|---|---|---|
| MTOR | PRKAA2 | 2475 | 5563 | Regulation | none | 19679549 |  Metformin, the most widely used drug in the treatment of type 2 diabetes, activates AMP kinase (AMPK), which negatively regulates mTOR.  | |
| MTOR | AMPK | 2475 | FPLX:AMPK | Regulation | none | 19679549 |  Metformin, the most widely used drug in the treatment of type 2 diabetes, activates AMP kinase (AMPK), which negatively regulates mTOR.  | |
| MTOR | PRKAA1 | 2475 | 5562 | Negative_regulation, Positive_regulation | none | 25591762 |  High glucose-induced extracellular matrix accumulation and mTOR activation were significantly inhibited by the co-treatment of rAAV-AMPKα1(312) (encoding constitutively active AMPKα1) whereas activated by r-AAV-AMPKα1D157A (encoding dominant negative AMPKα1).  | |
| MTOR | AMPK | 2475 | FPLX:AMPK | Regulation | none | 33714781 |  Besides, metformin inhibits cystic fibrosis transmembrane conductance regulator (CFTR)-mediated fluids secretion and the mammalian target of rapamycin (mTOR)-involved cyst formation negatively regulated by AMPK in autosomal dominant polycystic kidney disease (APDKD).  | |
| MTOR | AMPK | 2475 | FPLX:AMPK | Negative_regulation | none | 32245619 |  Humanin attenuates palmitate-induced hepatic lipid accumulation and insulin resistance via AMPK-mediated suppression of the mTOR pathway.  | |
| MTOR | AMPK | 2475 | FPLX:AMPK | Regulation | none | PMC4880882 |  Metformin has been shown to alter AMPK, a protein kinase that directly and indirectly regulates mTOR signaling via phosphorylation of Raptor and TSC2, respectively.  | |
| MTOR | AMPK | 2475 | FPLX:AMPK | Positive_regulation | none | PMC8945547 |  In hypopharyngeal cancer cells, p-mTOR was reduced through activation of ERK and AMPK signaling pathways by metformin, resulting in cell cycle arrest, apoptosis and autophagy triggering [].  | |
| MTOR | AMPK | 2475 | FPLX:AMPK | Positive_regulation | none | PMC5386770 |  Interestingly, Jin et al. proposed that Twist1 depletion sensitized NSCLC cells to cisplatin by stimulating AMPK-induced mTOR inhibition and subsequent reduction in Mcl-1 protein [].  | |
| Mtor | AMPK | 56718 | FPLX:AMPK | Regulation | none | PMC9526660 |  In addition, the mTOR is negatively regulated by AMPK, of which expression is up-regulated with suppressed autophagy.  | |
| MTOR | AMPK | 2475 | FPLX:AMPK | Negative_regulation, Positive_regulation | none | PMC6690605 |  Moreover, it also enhanced the lumican expression transcriptionally, which indicated that hypoxia-induced mTOR activation was blocked by activated AMPK.  | 
Interaction data is being assembled. This may take a while depending on result size and server load. You can use the link below to fetch the download at a later time. The link is valid at least 24h.